Status:
TERMINATED
A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin
Lead Sponsor:
Pfizer
Conditions:
Cachexia
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood co...
Eligibility Criteria
Inclusion
- Healthy subjects
Exclusion
- History of seizures, including childhood seizures.
- History of movement disorders or related neurological conditions.
- History of head trauma associated with loss of consciousness.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01262690
Start Date
November 1 2010
End Date
September 1 2011
Last Update
October 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511